Courier Capital LLC Dexcom Inc Transaction History

Courier Capital LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 15, 2024	SELL	$114.22 - $140.1 $52,769 - $64,726	-462 Reduced 3.76%	11,833 $1.64 Million
Q4 2023 Jan 17, 2024	SELL	$75.49 - $124.16 $7,322 - $12,043	-97 Reduced 0.78%	12,295 $1.53 Million
Q3 2023 Oct 13, 2023	SELL	$86.06 - $137.93 $22,117 - $35,448	-257 Reduced 2.03%	12,392 $1.16 Million
Q2 2023 Jul 31, 2023	BUY	$112.47 - $130.98 $1.42 Million - $1.66 Million	12,649 New	12,649 $1.63 Million

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Courier Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Courier Capital LLC with notifications on news.